Luzhu Biotech Overview
- Year Founded
-
2001
- Status
-
Public
- Employees
-
213
- Stock Symbol
-
02480
- Share Price
-
$1.95
- (As of Friday Closing)
Luzhu Biotech General Information
Description
Beijing Luzhu Biotechnology Co., Ltd. is a biotechnology company committed to developing human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. The Group's product pipeline consisted of three clinical-stage product candidates, including its Core Product, LZ901, and six pre-clinical-stage product candidates.
Contact Information
Website
www.luzhubiotech.comCorporate Office
- No. 3 Guangtong Street
- Zhangjiawan Tongzhou District
- Beijing
- China
Corporate Office
- No. 3 Guangtong Street
- Zhangjiawan Tongzhou District
- Beijing
- China
Luzhu Biotech Stock Performance
As of 13-Nov-2026, Luzhu Biotech’s stock price is $1.95. Its current market cap is $388M with 199M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.95 | $1.95 | $1.53 - $3.32 | $388M | 199M | 473.33 | -$0.10 |
Luzhu Biotech Financials Summary
As of 30-Jun-2026, Luzhu Biotech has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 304,198 | 572,183 | 523,495 | 674,355 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (18,114) | (15,819) | (20,250) | (33,698) |
| Net Income | (19,208) | (20,908) | (23,446) | (35,244) |
| Total Assets | 146,590 | 148,583 | 143,897 | 164,587 |
| Total Debt | 46,150 | 39,018 | 9,251 | 2,711 |
Luzhu Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Luzhu Biotech Patents
Luzhu Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7337935-B2 | Recombinant varicella zoster virus vaccine | Active | 29-Nov-2019 | ||
| AU-2020391074-A1 | Recombinant varicella-zoster virus (vzv) vaccine | Active | 29-Nov-2019 | ||
| AU-2020391074-B2 | Recombinant varicella-zoster virus (vzv) vaccine | Active | 29-Nov-2019 | ||
| CA-3125908-A1 | Recombinant varicella-zoster virus (vzv) vaccine | Active | 29-Nov-2019 | ||
| US-11993634-B2 | Recombinant varicella-zoster virus (vzv) vaccine | Active | 29-Nov-2019 | C07K14/005 |
Luzhu Biotech Signals
Luzhu Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Luzhu Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Luzhu Biotech FAQs
-
When was Luzhu Biotech founded?
Luzhu Biotech was founded in 2001.
-
Where is Luzhu Biotech headquartered?
Luzhu Biotech is headquartered in Beijing, China.
-
What is the size of Luzhu Biotech?
Luzhu Biotech has 213 total employees.
-
What industry is Luzhu Biotech in?
Luzhu Biotech’s primary industry is Drug Discovery.
-
Is Luzhu Biotech a private or public company?
Luzhu Biotech is a Public company.
-
What is Luzhu Biotech’s stock symbol?
The ticker symbol for Luzhu Biotech is 02480.
-
What is the current stock price of Luzhu Biotech?
As of 13-Nov-2026 the stock price of Luzhu Biotech is $1.95.
-
What is the current market cap of Luzhu Biotech?
The current market capitalization of Luzhu Biotech is $388M.
-
What is Luzhu Biotech’s annual earnings per share (EPS)?
Luzhu Biotech’s EPS for 12 months was -$0.10.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process